Investing.com - B.Riley has initiated coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and a $5.00 price target, representing a 172% upside from the current price of $1.84. According to ...

Donald Trump says another meeting set for next week while warning of ‘very steep’ consequences if Tehran doesn’t make a deal Indirect talks between Iran and the US on the future of Iran’s nuclear ...

HINGHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that it is ...

(Left-right) Kavita Bedi Bhattacharya, Managing Director and Head of Group SME Banking, UOB; Johnson Poh, Assistant Chief Executive, Enterprise Transformation and Innovation Group, IMDA; Rachel Bondi, ...

HINGHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that it is ...

Fintel reports that on October 15, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 325.00% Upside As of ...

Harel Gadot, CEO of Microbot Medical Inc. (NASDAQ:MBOT), was recently a guest on Benzinga's All Access. Microbot Medical makes the LIBERTY® Endovascular Robotic System, a single-use, fully disposable ...

TVET system hampered by limited tertiary institutions and students discovering accreditation too late 106,000 MBOT professionals report wage gains but face employer misconceptions limiting career ...

We recently published 10 Stocks Losing Big Amid Market Boom. Microbot Medical Inc. (NASDAQ:MBOT) is one of the worst performers on Thursday. Microbot extended its losing streak to a fourth consecutive ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Microbot Medical ( (MBOT)) has provided ...